ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 315 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q4 2020. The put-call ratio across all filers is 0.54 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $99,000 | -27.7% | 2,804 | -6.0% | 0.03% | +3.6% |
| Q1 2022 | $137,000 | -31.2% | 2,983 | -0.7% | 0.03% | -28.2% |
| Q4 2021 | $199,000 | +5.3% | 3,003 | -0.7% | 0.04% | -7.1% |
| Q3 2021 | $189,000 | +2.7% | 3,023 | +0.6% | 0.04% | +5.0% |
| Q2 2021 | $184,000 | -8.5% | 3,005 | -1.1% | 0.04% | -14.9% |
| Q1 2021 | $201,000 | -31.6% | 3,038 | -20.7% | 0.05% | -29.9% |
| Q4 2020 | $294,000 | -5.8% | 3,829 | -64.8% | 0.07% | -44.2% |
| Q1 2020 | $312,000 | -55.1% | 10,868 | -0.8% | 0.12% | -40.9% |
| Q4 2019 | $695,000 | +499.1% | 10,955 | +167.0% | 0.20% | +383.3% |
| Q3 2019 | $116,000 | -1.7% | 4,103 | -7.9% | 0.04% | +13.5% |
| Q2 2019 | $118,000 | – | 4,456 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WESTERN FINANCIAL Corp | 820,346 | $62,945,000 | 41.38% |
| Johnson & Johnson Innovation - JJDC, Inc. | 3,260,869 | $250,206,000 | 32.27% |
| Aquilo Capital Management, LLC | 365,926 | $28,078,000 | 5.84% |
| L1 Capital Pty Ltd | 298,687 | $23,127,000 | 4.32% |
| First Light Asset Management, LLC | 704,449 | $54,052,000 | 4.00% |
| ACUTA CAPITAL PARTNERS, LLC | 139,000 | $10,665,000 | 2.90% |
| Evolutionary Tree Capital Management, LLC | 48,265 | $3,703,000 | 2.82% |
| Parkman Healthcare Partners LLC | 127,171 | $9,758,000 | 2.50% |
| Capital Impact Advisors, LLC | 88,183 | $6,766,000 | 1.66% |
| Tri Locum Partners LP | 56,003 | $4,297,000 | 1.56% |